2025 Western States Conference Abstract Submission - Abstracts are Due by February 28, 2025
Please complete this form in its entirety. All information needed is included in this form. Do not email additional data. Please be sure to KEEP A COPY of all submitted information for your records. ALL SUBMISSIONS ARE FINAL. You will receive an auto-generated email when your abstract is successfully submitted. Be sure to check your clutter, junk or spam folders for your confirmation.
Presenter Information
Name (include capitalization)
*
First Name
Last Name
E-mail
*
Phone Number
*
Residency Program
*
Please type in your full residency program name
I'm a:
*
PGY1
PGY2
Fellow
Other
IRB Status
*
Pending
Received
Exempt - Quality Improvement Project
Other
Do you have any conflicts of interest to disclose prior to your presentation? i.e., Do you or your spouse have any financial interest/arrangements, affiliation or relationship with organizations which might be a conflict of interest.
*
Yes
No
Platform Presentation Category
Please Select
A1. Infectious Diseases - Anti-infective Agents
A2. Oncology - Anti-neoplastic and Non-anti-neoplastic Agents
A3. Cardiovascular Care - Cardiovascular Agents
A4. Gastrointestinal Care - Gastro or Nutritional
A5. Neuro-Psych or Pain Management Agents
A6. Diabetes Care - Diabetes Agents and Devices
B1. Ambulatory Care
B2. Community Practice
B3. Critical Care
B4. General Clinical Practice
B5. Long-Term, Geriatric or Hospice Care
B6. Pediatric or Gender Specific Care
B7. Pharmacokinetics
B8. Public Health
C1. Pharmacoeconomics, Admin or Financial Management
C2. Technology Management (Comp/InfoSys/Drug Dist)
D1. Medication Safety
E1. Managed Care
Abstract Information
Abstract Guidelines
Abstract Title
*
USE ALL CAPS FOR YOUR TITLE! This title will appear in print and may be no more than 75 characters (including spaces).
Abstract Text
*
Categories: Introduction, Metholodgy, Results, Conclusion
0/500
Learning Objective #1
*
Must begin with either list, describe or explain.
Presentation Keywords
*
Abortifacients
Accountable Care Organization
Acne
Acne Products
Acute Pancreatitis
Addiction
Adherence
Administration
Adverse Drug Reactions
Affordable Care Act
Aging
AIDS
Alcoholism
Aldosterone Receptor
Allergies
Alpha Adrenergic Agonists
Alpha-1 Receptor Agonist
Alpha-Glucosidase Inhibitors
Alpha/Beta-Adrenergic Blocking Agents
Alzheimer's Disease
Ambulatory Care
Aminoglycosides
Amphetamines
Amylinomimetics
Analgesics
Androgens
Anemia
Anesthetic Agents
Angina
Angiotensin Converting Enzyme (ACE) Inhibitor
Anorexia
Anorexiants
Antacids
Antiarrhythmic Agents
Antiarthritic Agents
Antiasthmatic Agents
Anticoagulant Agents
Anticoagulation
Anticonvulsant Agents
Antidearrheal Agents
Antidiabetic Agents
Antiemetic Agents
Antiepilectic Drugs (AEDs)
Antifungal Agents
Antihistamines
Antihyperlipidemic Agents
Antihypertensive Agents
Antimalarial Agents
Antimicrobial Agents
Antineoplastic Agents
Antiobesity Agents
Antiparasitic Agents
Antiplatelet Agents
Antipsychotic Agents
Antipyretic Agents
Antiretroviral Agents
Antispasmodic Agents
Antithrombotic Therapy
Antiviral Agents
Anxiety
Appetite Suppresants
Arrythmias
Arthritis
Asthma
Atherosclerosis
Atrial Fibrilation
Atrial Flutter
Attention Deficit Hyperactivity Disorder (ADHD)
Audits
Automation
Benighn Prostatic Hypertrophy (BPH)
Beta-2-Agonists
Beta-Adrenergic Blocking Agents
Beta-Blockers
Beta-Lactamase Inhibitors
Billing
Bioequivalence
Biotechnology
Bipolar Disorder
Bisphosphonates
Brain Injury
Bronchodilators
Burns and Scalds
Calcium Channel Blocking Agents
Calculations
Cancer
Carbapenems
Cardiology
Cardiovascular Disease
Cephalosporins and Related Products
Cerebrovascular Disease
Certification
Chemotherapy
Cholesterol Lowering Agents
Cholinergic Agents
Cholinesterase Inhibitors
Chronic Kidney Disease (CKD)
Chronic Obstructive Pulmonary
Disease (COPD)
Cirrhosis
Clinical Decision Support
Clinical Trials
Clotting Factors
Collaborative Drug Therapy Management (CDTM)
Colony Stimulating Factors
Common Cold
Communication
Community-Acquired Pneumonia (CP)
Compliance
Compounding
Congestive Heart Failure (CHF)
Constipation
Continuing Professional Development (CPD)
Contraception
Controlled Substances
Coronary Artery Disease (CAD)
Coronary Heart Disease (CHD)
Corticosteroids
Cough
COVID-19
COX-2 Inhibitors
Cystic Fibrosis
Cytokines
DDP-IV Inhibitors
Decongestants
Deep Vein Thrombosis (DVT)
Delivery System & Devices
Dementia
Depression
Dermatitis
Dermatology
Devices
Diabetes (DM)
Diagnostics
Dialysis
Diarrhea
Discharge Prescriptions
Disease Modifying Antirheumatic Drugs (DMARDs)
Diuretics
Diversity
Documentation
Dopamine Agonists
Drug Diversion
Drug Dosing
Drug Enforcement Administration
Drug Information
Drug Interactions
Drug Manufacturing
Drug Overdose
Drug Use Evaluation (DUE)
Dyslipidemia
E-Prescribing
Ebola
Eczema
Education
Electrolye Abnormalities or Electrolyte Management
Embolism
Emergency Medicine
Emergency Preparedness
End of Life
Endocrinology
Epilepsy
Erectile Dysfunction
Estrogen Receptor Antagonists
Estrogens
Ethics
Evidence-Based Medicine
Evironmental Aspects
Fever
Fibrinolytics
Fluroquinolones
Food and Drug Administration (FDA)
Gastroenterology
Gastroesophageal Reflux Disorder (GERD)
Geriatrics
Glaucoma
Glucose Monitoring Devices
Glycoprotein IIb/IIIa Blockers
Gonadotropin-Releasing Hormone Agents
Gout
Growth Hormone Receptor Antagonists
Gynecology
H2-Receptor Antagonists
Headache
Health Literacy
Healthcare Reform
Heartburn
Hematology
Hemorrhiods
Hepatitis
Hepatology
Herbal Medications
Herbal Medicine
Herbal Supplements
Herpes
HIPAA
Histamine Antagonists
Hormones
Human Immunodeficiency Virus (HIV)
Hypercholesterolemia
Hyperglycemia
Hyperlipidemia
Hypertension
Hyperuricemia
Immunizations
immunosuppressive Agents
immunotherapy
Importation
Impotence Agents
Infectious Disease
Infertility
Inflammatory Bowel Disease
Influenza
Informatics
Inhalants
Insomnia
Insulin
Insulin Delivery Systems
Insurance
Inter-professional
Inter-professional Collaborative Practice
Inter-professional Education
Interferons
Inventory Control
Investigational agents
Irritable Bowel Syndrome
JCAHO
Laboratory
Law
Laxatives
Leadership
Leukotriene Receptor Antagonists
lmmue Globulin
lmmunomodulators
lncretin Mimetics
lnotropes
Long-Term Care
Low Molecular Weight Heparins (LMWH)
Macrolides
Managed Care
Management
MAO Inhibitors
Marijuana
Marketing
Medicaid
Medical Errors
Medical Home
Medical Marijuana
Medical Record
Medicare
Medication Delivery System
Medication Disposal
Medication Errors
Medication Reconciliation
Medication Safety
Medication Therapy Management
Men's Health
Meningitis
Menopause
Mental Health
Metabolic Disorders
Migraine
Monitoring
Monoclonal Antibody
Multiple Sclerosis
Myocardial Infarction
Narcotics
Nasal Decongestants
National Guidelines
Nausea
Neonatology
Nephrology
Neurology
Neutropenia
New Drugs
Nicotine Replacement
Nitroglycerin
Non-compliance
Nonadrenergic Agents
Nonsteroidal Anti·lnflammatory Drugs (NSAIDs)
Nuclear
Nutrition
Nutritional Supplements
Obesity
Obstetrics
Oncology
Opiates
Opioids
Opthamalics
Opthamology
Oral Contraceptives
Order Entry
Orthopaedics
Osteoarthritis
Ostomy
Ouinolones
Outcomes
Over-the-Counter (OTC) Products
Over-the-Counter Treatment
Pain
Pain Management
Parkinson's Disease
Pediatrics
Pelvic Inflammatory Disease (PID)
Penicillins
Peripheral Arterial Disease (PAD)
Pharmaceutical Care
Pharmacoeconomics
Pharmacogenomics
Pharmacokinetics
Pharmacy Calculations
Phosphodiesterase Inhibitor
Platelet Disorders
Pneumonia
Polypharmacy
Precepting
Pregnancy
Premenstrual Syndrome (PMS)
Preventative Medicine
Probiotics
Progestins
Protease Inhibitors
Proton Pump lnhlbitors
Psoriasis
Psychiatry
Psychology
Psychotherapy
Public Health
Pulmonary Disease
Pulmonary Embolism
Pulmonary Hypertension
Quality Assurance
Quality Improvement
Radiology
Radiopharmaceuticals
Regulation
Reimbursement
REMS
Renal Disease
Research
Resistance
Restless Leg Syndrome
Restricted Drug Distribution
Rheumatoid Arthritis
Rhinitis
Safety
Salicylates
Schizphrenia
Sedation
Sedatives and Hypnotic
Seizure
Selective Serotonin Reuptake Inhibitors ((SSRI)~
Self Monitoring Devices
Sepsis
Sexual Dysfunction
Sexually Transmitted Diseases
Shock
Sickle Cell Disease
Sinusitis
Skeletal Muscle Relaxants
Skin Disorders
Sleep Apnea
Smallpox
Smoking Cessation
Spanish Language
Spinal Cord Injury
Sports Medicine
Statins (HMG-COA) Reductase Inhibitors
Sterile Compounding
Stevens-Johnson Syndrome
Stimulants
Stool Softeners
Stroke
Substance Abuse
Sudden Infant Death Syndrome (SIDS)
Sulfonamides
Sunburn
Surgery
Systemic Lupus Erythemtosus (SLE)
Teaching
Technology
Telemedicine
Telepharmacy
Terrorism
Testosterone
Tetracyclines
Third Party Payers
Thrombolytic Agents
Thrombosis
Thyroid Disease
Tissue Plasminogen - (IPA)
Topical Agents
Toxicology
Transient Ischemic Attach (TIA)
Transition of Care
Transplantation
Trauma
Ulcers
Ulveratice Colitis
Unfractionated Hepal1na
Uremia
Uricolytic Agents
Uricosuric ~
Urinary Incontinence
Urology
USP Chapter 797
Vaccines
Varicella Zoster Virus
Vasodilators
Ventilation
Veterinary Medicine
Viral Infections
Vitamins
Weight Management
Withdrawl
Women's Health
Workplace Issues
Wound Healing
Xanthine Oxidase Inhibitors
Please select 1 - 2 keywords you would use to classify your presentation. Use Ctrl or Cmd to select multiple terms.
Will off-label drug use be discussed?
*
Yes
No
Digital Signature - Please read the acknowledgement and type your full name into the box below.
*
By typing your name in this box, you acknowledge this is your final submission, it is your original work, and you have kept a copy of your submission for your records.
Upload Abstract
*
Upload a File
Only PDF files will be accepted.
Cancel
of
SUBMIT FORM
Should be Empty: